Neurology News

The FDA has approved Neuronetics’ transcranial magnetic stimulation system, called NeuroStar, as an adjunct treatment for adults with obsessive compulsive disorder.

The HHS Office of Climate Change and Health Equity has launched Climate and Health Outlook, a new climate-related public health information series, according to a press release.

U.S. death data show the burden of ischemic heart disease, cerebrovascular disease and HF deaths vary significantly across Asian American subgroups, emphasizing the importance of tailoring CVD prevention and management strategies.

Alzamend Neuro Inc. has announced the launch of a phase 2A trial for its AL001 treatment for mild to moderate Alzheimer’s dementia.

The Indian Health Service has announced it will allocate $5 million in funding toward resources to address Alzheimer’s disease among tribal communities.

In-hospital outcomes for acute ischemic stroke patients with solid organ malignancy varied depending on the type of cancer and use of stroke interventions, according to a study published in Neurology.

Epilepsy was not a significant factor among adults who had been hospitalized for attempted suicide, according to a study published in the Journal of Clinical Psychiatry.

CHICAGO — The issue of physician burnout has been increasingly recognized over the past decade, and it will persist until changes are made at the organizational level, according to speakers at the ACP Internal Medicine Meeting.

CHICAGO — In 1915, the American Medical Women’s Association became the first national organization of women physicians.

Digital therapeutics company Big Health has announced a partnership with the University of Oxford for a new study evaluating Sleepio, an online program designed to improve sleep and mental health for stroke patients.